MetaCap

Kestra Medical Technologies Balance Sheet

NASDAQ: KMTSHealth CareMedical/Dental InstrumentsUSD

26.98+1.21 (+4.70%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Kestra Medical Technologies financial position

At the end of fiscal 2026, Kestra Medical Technologies reported total assets of $358.5 million, up 21.2% from a year earlier against total liabilities of $98.8 million. Shareholders' equity stood at $259.7 million, or 72.4% of assets. The company held $99.7 million in cash and equivalents against $42.6 million of debt, a net cash position of $57.1 million.

The current ratio (current assets divided by current liabilities) was 4.41, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.16.

Summary generated from market data by MetaCap's automated system. Methodology

Kestra Medical Technologies balance sheet (annual)

Kestra Medical Technologies annual balance sheet
Fiscal year (USD)FY 20262026-04-30FY 20252025-04-30FY 20242024-04-30
Cash & Equivalents99.71M237.59M8.25M
Short-Term Investments96.72M——
Receivables14.54M8.08M2.00M
Total Current Assets222.36M255.33M14.91M
Property, Plant & Equipment59.09M34.83M26.11M
Long-Term Investments65.77M——
Total Assets358.46M295.74M45.95M
Accounts Payable27.30M23.96M23.89M
Total Current Liabilities50.37M37.98M32.97M
Long-Term Debt42.65M41.10M42.54M
Total Liabilities98.81M90.34M78.22M
Shareholders' Equity259.66M205.41M-209.38M
Retained Earnings-651.86M-520.25M-406.44M
Total Debt42.65M41.10M42.54M
Net Cash (Debt)153.78M196.50M-34.29M
Shares Outstanding58.38M51.35M105.81K

This table shows 3 annual periods of Kestra Medical Technologies's balance sheet, from FY 2026 back to FY 2024, across 16 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow KMTS's reporting calendar. What is a balance sheet?

More financial data